Ladenburg Thalmann Financial Services’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$11K Hold
10
﹤0.01% 4446
2019
Q3
$6K Hold
10
﹤0.01% 4607
2019
Q2
$10K Sell
10
-15
-60% -$14.5K ﹤0.01% 4433
2019
Q1
$30K Buy
25
+5
+25% +$5.2K ﹤0.01% 3751
2018
Q4
$13K Buy
+20
New +$21K ﹤0.01% 4129

Other funds holding LABU

Ladenburg Thalmann Financial Services's LABU Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q4 2019 at 10 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #4446.

Ladenburg Thalmann Financial Services first reported a position in LABU in Q4 2018 and has held it in 5 quarters since. The position peaked at $30K in Q1 2019. 22 funds tracked by Wall St. Rank hold LABU as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 10 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $11K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q4 2019.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4446 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and has held it in 5 quarters since.
  • Ladenburg Thalmann Financial Services's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $30K in Q1 2019.
  • 22 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.